Pitra Soledad, Stern Javier E
Department of Physiology, Medical College of Georgia, Augusta University, Augusta, Georgia.
Department of Physiology, Medical College of Georgia, Augusta University, Augusta, Georgia
Am J Physiol Heart Circ Physiol. 2017 Sep 1;313(3):H548-H557. doi: 10.1152/ajpheart.00216.2017. Epub 2017 Jun 16.
Recent studies have supported an important contribution of prorenin (PR) and its receptor (PRR) to the regulation of hypothalamic, sympathetic, and neurosecretory outflows to the cardiovascular system, including systemic release of vasopressin (VP), both under physiological and cardiovascular disease conditions. Still, the identification of precise cellular mechanisms and neuronal/molecular targets remain unknown. We have recently shown that PRR is expressed in VP neurons and that their activation increases neuronal activity. However, the underlying ionic channel mechanisms are undefined. Here, we performed patch-clamp electrophysiology from identified VP neurons in acute hypothalamic slices obtained from enhanced green fluorescent protein-VP transgenic rats. Voltage-clamp recordings showed that PR inhibited the magnitude of A-type K current (; 50% at -25 mV), a subthreshold voltage-dependent current that restrains VP firing activity. PR also increased the inactivation rate of and shifted the steady-state voltage-dependent inactivation function toward more hyperpolarized membrane potential (7 mV shift), thus resulting in less channel availability to be activated at any given membrane potential. PR also inhibited a sustained component of ("window" current). PR-mediated changes in action potential waveform and increased firing activity were occluded when was blocked by 4-aminopyridine. Finally, PR failed to increase superoxide production within the supraoptic nucleus/paraventricular nucleus, and PR excitatory effects persisted in slices treated with the SOD mimetic tempol. Taken together, these experiments indicated that PR excitatory effects on vasopressin neurons involve inhibition of , due, in part, to increases in its voltage-dependent inactivation properties. Moreover, our results indicate that PR effects did not involve an increase in oxidative stress. Here, we demonstrate that prorenin/the prorenin receptor is an important signaling unit for the regulation of vasopressin firing activity and, thus, systemic hormonal release. We identified A-type K channels as key molecular targets mediating prorenin stimulation of vasopressin neuronal activity, thus standing as a potential therapeutic target for neurohumoral activation in cardiovascular disease.
近期研究表明,在生理状态和心血管疾病状态下,肾素原(PR)及其受体(PRR)对下丘脑、交感神经以及向心血管系统发出的神经分泌输出的调节具有重要作用,这包括血管加压素(VP)的全身释放。然而,精确的细胞机制以及神经元/分子靶点仍不明确。我们最近发现PRR在VP神经元中表达,且其激活会增加神经元活性。但是,潜在的离子通道机制尚不清楚。在此,我们利用从增强型绿色荧光蛋白-VP转基因大鼠获取的急性下丘脑切片中已鉴定的VP神经元进行膜片钳电生理实验。电压钳记录显示,PR抑制了A 型钾电流的幅度(在-25 mV时约为50%),这是一种阈下电压依赖性电流,可抑制VP放电活动。PR还提高了该电流的失活速率,并使稳态电压依赖性失活功能向更超极化的膜电位方向移动(约7 mV的偏移),从而导致在任何给定膜电位下可被激活的通道可用性降低。PR还抑制了该电流的一个持续成分(“窗口”电流)。当4-氨基吡啶阻断该电流时,PR介导的动作电位波形变化和放电活动增加被消除。最后,PR未能增加视上核/室旁核内的超氧化物生成,并且在使用超氧化物歧化酶模拟物tempol处理的切片中,PR的兴奋作用仍然存在。综上所述,这些实验表明PR对血管加压素神经元的兴奋作用涉及对该电流的抑制,部分原因是其电压依赖性失活特性的增加。此外,我们的结果表明PR的作用并不涉及氧化应激的增加。在此,我们证明肾素原/肾素原受体是调节血管加压素放电活动以及全身激素释放的重要信号单位。我们确定A 型钾通道是介导肾素原刺激血管加压素神经元活动的关键分子靶点,因此可作为心血管疾病中神经体液激活的潜在治疗靶点。